[1]
“HYPERCOAGULABILITY AND THROMBOTIC RISK IN BETA-THALASSEMIA: CLINICAL AND LABORATORY INSIGHTS”, mij, vol. 5, no. 1, pp. 33–38, Mar. 2026, doi: 10.35120/medisij0501033s.